Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period, which included revenue from its domestic branded formulation ...
Anonymous image hosting can be important when wanting to upload content that might be sensitive or controversial, especially if you're a journalist or a whistleblower looking to expose something ...
The Competition Commission has imposed a penalty of Rs 40 lakh on the investment manager of Goldman Sachs AIF for failing to notify the regulator about the more than four-year-old deal that gives the ...
Under the deal, Goldman Sachs AIF Scheme-1 (GS AIF) had acquired optionally convertible debentures (OCDs) issued by Biocon Biologics. The regulator has penalised GS AIMPL for failing to notify the ...
The deal involved an option to acquire up to a 3.81% stake in Biocon Biologics. Goldman Sachs AIF Scheme-1 (GS AIF) had acquired optionally convertible debentures (OCDs) from Biocon Biologics ...
While traditional web hosting platforms can host these images, they’re not designed for professionals like photographers, artists, or media creators who rely on high-quality image hosting to ...
Am J Health Syst Pharm. 2007;64(12):1265-1273. Vildagliptin has been shown to be relatively safe in clinical trials; however, long-term evaluation of safety data and clinical experience of the ...
Biocon share price: The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year. Listen to Story It had closed at Rs 364.80 in the previous ...
I have tested multiple AI models, particularly image models and they each have something unique to offer. AI image generation has come a long way in a few short years. The first version of ...
Regulatory compliance at the Malaysian site paves the way for commercial opportunities for B-Aspart. We believe the contractual cycle will pose a limited hurdle, as there is currently no biosimilar ...
Biocon share price: This upgrade reflects a more positive outlook on the company following recent favorable news flow, particularly concerning its biologics business. Stocks to buy today: CLSA ...
Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes.